Moreover, CD44 (Box 1), one of the main cell surface receptors for the ECM hyaluronan, is implicated in obesity and Type 2 diabetes, as genetic ablation of CD44 or its pharmacological inhibition improves diet-induced disruptions of glucose homeostasis in mice [7, 43, 44]. The gene discussed is CD44; the disease is obesity disorder.